Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN

K Menck, C Scharf, A Bleckmann, L Dyck… - Journal of molecular …, 2015 - academic.oup.com
K Menck, C Scharf, A Bleckmann, L Dyck, U Rost, D Wenzel, VM Dhople, L Siam, T Pukrop
Journal of molecular cell biology, 2015academic.oup.com
Tumor cells secrete not only a variety of soluble factors, but also extracellular vesicles that
are known to support the establishment of a favorable tumor niche by influencing the
surrounding stroma cells. Here we show that tumor-derived microvesicles (T-MV) also
directly influence the tumor cells by enhancing their invasion in a both autologous and
heterologous manner. Neither the respective vesicle-free supernatant nor MV from benign
mammary cells mediate invasion. Uptake of T-MV is essential for the proinvasive effect. We …
Abstract
Tumor cells secrete not only a variety of soluble factors, but also extracellular vesicles that are known to support the establishment of a favorable tumor niche by influencing the surrounding stroma cells. Here we show that tumor-derived microvesicles (T-MV) also directly influence the tumor cells by enhancing their invasion in a both autologous and heterologous manner. Neither the respective vesicle-free supernatant nor MV from benign mammary cells mediate invasion. Uptake of T-MV is essential for the proinvasive effect. We further identify the highly glycosylated form of the extracellular matrix metalloproteinase inducer (EMMPRIN) as a marker for proinvasive MV. EMMPRIN is also present at high levels on MV from metastatic breast cancer patients in vivo. Anti-EMMPRIN strategies, such as MV deglycosylation, gene knockdown, and specific blocking peptides, inhibit MV-induced invasion. Interestingly, the effect of EMMPRIN-bearing MV is not mediated by matrix metalloproteinases but by activation of the p38/MAPK signaling pathway in the tumor cells. In conclusion, T-MV stimulate cancer cell invasion via a direct feedback mechanism dependent on highly glycosylated EMMPRIN.
Oxford University Press